Delays Over Pricing Hold Back India's Vital Vaccine Rollout
Delays Over Pricing Hold Back India's Vital Vaccine Rollout
On Sunday, Serum's billionaire Chief Executive Officer Adar Poonawalla said Indian officials have "orally" agreed to buy 100 million doses at a "special price" of 200 rupees a shot, below the about $4 to $5 price tag given to the U.K. government.
A health worker opens a deep freezer during a Covid-19 vaccine dry run in Delhi, Jan. 2.
Highlights
Officials have "orally" agreed to buy 100 million doses at Rs 200: Serum
Over 10 million people have been affected by the virus in India
As major countries like the U.S. and China race to vaccinate their populations with rapidly approved shots, tens of millions of doses prepared for India are sitting in storage despite having been authorized for use.